SINOPHARM

Forecast & Rating15 analysts currently cover SINOPHARM, with about 66.7% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$21.20, about 31.5% upside from the current price of HK$16.12. Price targets range from HK$17.00 to HK$27.69 — a wide spread, showing clear disagreement over just how much SINOPHARM can rise. Historically, about 29.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study SINOPHARM closely still see room for the stock to rise. Data as of Aug 26, 2026; for reference only and not investment advice.